Literature DB >> 12774951

Linkage to the CCM2 locus and genetic heterogeneity in familial cerebral cavernous malformation.

Nicolas Dupré1, Dominique J Verlaan, Collette K Hand, Sandra B Laurent, Gustavo Turecki, W Jeptha Davenport, Nicola Acciarri, Johannes Dichgans, Akio Ohkuma, Adrian M Siegel, Guy A Rouleau.   

Abstract

BACKGROUND: Cerebral cavernous malformation (CCM) is a form of intracranial vascular disease that may arise sporadically or be dominantly inherited. Linkage studies have revealed genetic heterogeneity among the dominantly inherited forms suggesting the existence of at least three loci called CCM1, CCM2 and CCM3.
METHODS: In the present study, we screened five families with dominantly inherited CCM for CCM1 gene mutations with denaturing high performance liquid chromatography (DHPLC). Then, we performed linkage analysis and haplotyping on these five families using highly polymorphic markers at the candidate CCM loci.
RESULTS: None of the five families tested with DHPLC were found to have mutations in the CCM1 gene. Based on haplotyping, we identified three families segregating alleles for CCM2, while two families segregated alleles for CCM3. Using linkage analysis, we could confirm that one family (IFCAS-1) had a positive Lod score of 2.03 (p<0.0001) at the CCM2 locus using marker D7S678.
CONCLUSIONS: The present study is the first one to replicate linkage at the CCM2 locus and provides a fifth family identified as such. It also supports the concept of genetic heterogeneity in CCM, identifying four other families that showed no mutations in the CCM1 gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12774951     DOI: 10.1017/s0317167100053385

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  13 in total

1.  Systems biology and proteomic analysis of cerebral cavernous malformation.

Authors:  Alexander R Edelmann; Sarah Schwartz-Baxter; Christopher F Dibble; Warren C Byrd; Jim Carlson; Ivandario Saldarriaga; Sompop Bencharit
Journal:  Expert Rev Proteomics       Date:  2014-03-31       Impact factor: 3.940

Review 2.  Genetics of cerebral cavernous malformations: current status and future prospects.

Authors:  H Choquet; L Pawlikowska; M T Lawton; H Kim
Journal:  J Neurosurg Sci       Date:  2015-04-22       Impact factor: 2.279

3.  [Familial cavernous malformations of the central nervous system. A clinical and genetic study of 15 German families].

Authors:  A M Siegel; H Bertalanffy; J J Dichgans; C E Elger; H Hopf; N Hopf; M Keidel; A Kleider; G Nowak; R A Pfeiffer; J Schramm; S Spuck; H Stefan; U Sure; C R Baumann; G A Rouleau; D J Verlaan; E Andermann; F Andermann
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

4.  Calm the raging hormone - A new therapeutic strategy involving progesterone-signaling for hemorrhagic CCMs.

Authors:  Jun Zhang; Johnathan S Abou-Fadel
Journal:  Vessel Plus       Date:  2021-07-05

5.  Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5-trisphosphate.

Authors:  Christopher F Dibble; Jeremy A Horst; Michael H Malone; Kun Park; Brenda Temple; Holly Cheeseman; Justin R Barbaro; Gary L Johnson; Sompop Bencharit
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

6.  Inherited cavernous malformations of the central nervous system: clinical and genetic features in 19 Swiss families.

Authors:  C Graeni; F Stepper; M Sturzenegger; A Merlo; D J Verlaan; F Andermann; C R Baumann; F Bonassin; D Georgiadis; R W Baumgartner; G A Rouleau; A M Siegel
Journal:  Neurosurg Rev       Date:  2009-09-17       Impact factor: 3.042

7.  Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke.

Authors:  Aniket V Gore; Maria Grazia Lampugnani; Louis Dye; Elisabetta Dejana; Brant M Weinstein
Journal:  Dis Model Mech       Date:  2008-10-28       Impact factor: 5.758

8.  Biological activity of paediatric cerebral cavernomas: an immunohistochemical study of 28 patients.

Authors:  Wuttipong Tirakotai; Sandra Fremann; Niels Soerensen; Wolfgang Roggendorf; Adrian M Siegel; Hans Dieter Mennel; Yuan Zhu; Helmut Bertalanffy; Ulrich Sure
Journal:  Childs Nerv Syst       Date:  2006-02-18       Impact factor: 1.475

9.  Mutations within the MGC4607 gene cause cerebral cavernous malformations.

Authors:  C Denier; S Goutagny; P Labauge; V Krivosic; M Arnoult; A Cousin; A L Benabid; J Comoy; P Frerebeau; B Gilbert; J P Houtteville; M Jan; F Lapierre; H Loiseau; P Menei; P Mercier; J J Moreau; A Nivelon-Chevallier; F Parker; A M Redondo; J M Scarabin; M Tremoulet; M Zerah; J Maciazek; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-22       Impact factor: 11.025

10.  Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.

Authors:  Christina L Liquori; Michel J Berg; Adrian M Siegel; Elizabeth Huang; Jon S Zawistowski; T'Prien Stoffer; Dominique Verlaan; Fiyinfolu Balogun; Lori Hughes; Tracey P Leedom; Nicholas W Plummer; Milena Cannella; Vittorio Maglione; Ferdinando Squitieri; Eric W Johnson; Guy A Rouleau; Louis Ptacek; Douglas A Marchuk
Journal:  Am J Hum Genet       Date:  2003-11-17       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.